Dow Jones

40 211,72

0,53%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:TEVA

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
21/02/2022	14h00	PR Newswire (US)	Bleichmar Fonti & Auld LLP Announce a Proposed Class Action Settlement Involving Purchasers of Teva Pharmaceutical Securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
15/02/2022	13h32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
14/02/2022	09h00	Business Wire	La notice de COPAXONE® mentionne désormais son utilisation chez les mères allaitantes atteintes de sclérose en plaques rémittente	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
14/02/2022	09h00	Business Wire	COPAXONE®-Etikett indiziert nun Einsatz für stillende Mütter mit schubförmig verlaufender Multipler Sklerose	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
11/02/2022	18h26	Edgar (US Regulatory)	Schedule 13g	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/02/2022	22h16	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/02/2022	09h00	Business Wire	COPAXONE® Label Now Indicates Its Use in Breastfeeding Mothers with Relapsing Multiple Sclerosis	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
09/02/2022	22h12	Edgar (US Regulatory)	Annual Report (10-k)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
09/02/2022	13h01	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
09/02/2022	13h00	Business Wire	Teva Reports Fourth Quarter and Full Year 2021 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
07/02/2022	17h01	Dow Jones News	Teva Pharmaceuticals in Deal With Texas Settling Opioid-Related Claims	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
07/02/2022	16h12	Business Wire	Teva Reaches Agreement With Texas to Settle the State’s Opioid-Related Claims	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/02/2022	14h00	Business Wire	Research Finds COVID Pandemic Worsened Health Equity Gap	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
19/01/2022	13h11	TipRanks	Teva to Pay $420M to Settle Shareholders’ Generic Drug Pricing Lawsuit — Report	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
18/01/2022	14h00	Business Wire	Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance at 8 a.m. ET on February 9, 2022	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
04/01/2022	19h35	Business Wire	Teva to Present at the 40th Annual J.P. Morgan Healthcare Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
31/12/2021	17h06	TipRanks	Teva Found Guilty of Fueling New York Opioid Crisis	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
30/12/2021	19h29	Business Wire	Teva Statement Following New York Jury Ruling in Opioids Trial	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
30/12/2021	19h05	Dow Jones News	Teva Fueled Opioid Addiction in New York, Jury Finds -- Reuters	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
29/12/2021	09h27	TipRanks	Teva Long-Term Prospects Bright, Despite Headwinds	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/12/2021	10h11	TipRanks	Teva Partners with Tikun Olam-Cannbit to Sell Medical Cannabis Products – Report	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
23/12/2021	14h54	TipRanks	Teva Launches First Generic of Naloxone Hydrochloride Nasal Spray in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
22/12/2021	22h30	Business Wire	Teva Announces Launch of First-to-Market Generic Version of Narcan® (Naloxone Hydrochloride Nasal Spray), in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
06/12/2021	15h43	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/12/2021	14h00	Business Wire	Teva Announces Launch of an Authorized Generic of Epiduo® Forte Gel (adapalene and benzoyl peroxide gel 0.3%/2.5%), in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
25/11/2021	18h00	GlobeNewswire Inc.	Quantum Genomics signs an exclusive license agreement with Teva Israel Ltd.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/11/2021	15h17	Business Wire	Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
09/11/2021	11h56	Business Wire	Von der Effektivität im Rahmen klinischer Versuchsreihen zur tatsächlichen Wirksamkeit - erste Daten zu AJOVY® ▼ (Fremanezumab) aus dem European Real World Evidence Programm	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
09/11/2021	11h54	Business Wire	De l'efficacité clinique à l'efficacité en monde réel : les premières données AJOVY® ▼ ▼ (frémanezumab) du programme European Real World Evidence	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/11/2021	10h25	Business Wire	From Clinical Trial Efficacy to Real-World Effectiveness First AJOVY® ▼ (fremanezumab) Data from European Real World Evidence Program	NYSE:TEVA	Teva Pharmaceutical Industries Ltd